DK1117676T3 - Propanolaminderivater bundet til galdesyrer til behandling af forstyrrelser i lipidstofskiftet - Google Patents

Propanolaminderivater bundet til galdesyrer til behandling af forstyrrelser i lipidstofskiftet

Info

Publication number
DK1117676T3
DK1117676T3 DK99947385T DK99947385T DK1117676T3 DK 1117676 T3 DK1117676 T3 DK 1117676T3 DK 99947385 T DK99947385 T DK 99947385T DK 99947385 T DK99947385 T DK 99947385T DK 1117676 T3 DK1117676 T3 DK 1117676T3
Authority
DK
Denmark
Prior art keywords
lipid metabolism
bile acids
treat disorders
derivatives bound
propanolamine derivatives
Prior art date
Application number
DK99947385T
Other languages
Danish (da)
English (en)
Inventor
Alfons Enhsen
Heiner Glombik
Werner Kramer
Eugen Falk
Siegfried Stengelin
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1117676T3 publication Critical patent/DK1117676T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK99947385T 1998-10-02 1999-09-18 Propanolaminderivater bundet til galdesyrer til behandling af forstyrrelser i lipidstofskiftet DK1117676T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19845403A DE19845403B4 (de) 1998-10-02 1998-10-02 Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
EP99947385A EP1117676B1 (de) 1998-10-02 1999-09-18 Mit gallensäuren verknüpfte propanolaminderivate zur behandlung von lipidstoffwechselstörungen

Publications (1)

Publication Number Publication Date
DK1117676T3 true DK1117676T3 (da) 2004-12-20

Family

ID=7883185

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99947385T DK1117676T3 (da) 1998-10-02 1999-09-18 Propanolaminderivater bundet til galdesyrer til behandling af forstyrrelser i lipidstofskiftet

Country Status (22)

Country Link
US (1) US6180618B1 (https=)
EP (1) EP1117676B1 (https=)
JP (1) JP4598953B2 (https=)
KR (1) KR20010075511A (https=)
CN (1) CN1227259C (https=)
AR (1) AR035003A1 (https=)
AT (1) ATE273991T1 (https=)
AU (1) AU757366B2 (https=)
BR (1) BR9915019A (https=)
CA (1) CA2346085A1 (https=)
DE (2) DE19845403B4 (https=)
DK (1) DK1117676T3 (https=)
ES (1) ES2226440T3 (https=)
HK (1) HK1040717A1 (https=)
HU (1) HUP0103570A3 (https=)
ID (1) ID29353A (https=)
PL (1) PL347106A1 (https=)
PT (1) PT1117676E (https=)
RU (1) RU2234512C2 (https=)
TR (1) TR200100897T2 (https=)
WO (1) WO2000020437A1 (https=)
ZA (1) ZA200102586B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
US7161008B2 (en) * 2002-05-03 2007-01-09 Sanofi - Aventis Deutschland GmbH Optically active β-aminoketones, optically active 1,3-amino alcohols and processes for preparing them
GB0213669D0 (en) * 2002-06-14 2002-07-24 Astrazeneca Ab Chemical compounds
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
GB0817969D0 (en) * 2008-10-01 2008-11-05 Axcess Ltd Pharmaceutical composition
EP2575821B1 (en) 2010-05-26 2015-08-12 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
CA2852957C (en) 2011-10-28 2020-08-04 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
CN104023727B (zh) 2011-10-28 2017-04-05 鲁美纳医药公司 用于治疗小儿胆汁淤积性肝病的胆汁酸再循环抑制剂
US20140275090A1 (en) 2013-03-15 2014-09-18 Lumena Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease
CN105228615A (zh) 2013-03-15 2016-01-06 鲁美纳医药公司 用于治疗巴雷特食管和胃食管返流疾病的胆汁酸再循环抑制剂
PL3923943T3 (pl) 2019-02-12 2024-12-09 Mirum Pharmaceuticals, Inc. Zależna od genotypu i dawki odpowiedź na asbti u pacjentów z niedoborem pompy eksportu soli żółciowych

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI892341A7 (fi) 1988-06-10 1989-12-11 Hoffmann La Roche Propanoliamiinijohdannaisia
GB2250634A (en) * 1990-12-04 1992-06-10 Marconi Gec Ltd Point contact diodes
NZ240846A (en) 1990-12-06 1994-04-27 Hoechst Ag Dimeric bile acid derivatives; preparatory processes and pharmaceutical compositions
JP2616845B2 (ja) * 1991-02-21 1997-06-04 清水化学株式会社 システノール酸又はその胆汁酸抱合体を含有する血中コレステロール低下剤
GB9203347D0 (en) * 1992-02-17 1992-04-01 Wellcome Found Hypolipidaemic compounds
DK0557879T3 (da) * 1992-02-22 1997-06-16 Hoechst Ag 4-amino-2-ureido-pyrimidin-5-carboxylsyreamider, fremgangsmåde til deres fremstilling, lægemidler med indhold af disse forbindelser og deres anvendelse
TW289021B (https=) * 1993-05-08 1996-10-21 Hoechst Ag
EP0624593A3 (de) 1993-05-08 1995-06-07 Hoechst Ag Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel.
DK0869121T3 (da) * 1997-04-04 2004-09-20 Aventis Pharma Gmbh Hypolipidæmiske propanolaminderivater

Also Published As

Publication number Publication date
HUP0103570A3 (en) 2003-01-28
DE19845403B4 (de) 2005-02-10
ID29353A (id) 2001-08-23
BR9915019A (pt) 2001-08-14
EP1117676B1 (de) 2004-08-18
DE59910300D1 (de) 2004-09-23
TR200100897T2 (tr) 2001-10-22
PT1117676E (pt) 2004-11-30
PL347106A1 (en) 2002-03-25
CN1321166A (zh) 2001-11-07
EP1117676A1 (de) 2001-07-25
AR035003A1 (es) 2004-04-14
WO2000020437A1 (de) 2000-04-13
ZA200102586B (en) 2001-10-03
HUP0103570A2 (hu) 2002-02-28
JP4598953B2 (ja) 2010-12-15
RU2234512C2 (ru) 2004-08-20
ATE273991T1 (de) 2004-09-15
JP2002526550A (ja) 2002-08-20
HK1040717A1 (zh) 2002-06-21
AU6085599A (en) 2000-04-26
KR20010075511A (ko) 2001-08-09
AU757366B2 (en) 2003-02-20
US6180618B1 (en) 2001-01-30
ES2226440T3 (es) 2005-03-16
CN1227259C (zh) 2005-11-16
DE19845403A1 (de) 2000-04-13
CA2346085A1 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
PT944631E (pt) Novos derivados substituidos de pirazole para tratamento de doencas cardiovasculares
NO995077D0 (no) Fremgangsmåte ved anvendelse av cyklooksygenase-2 inhibitorer i forhindringen av kardiovaskulaere forstyrrelser
IS7648A (is) Dífenýlasetídínónafleiður til að meðhöndla fituefnaskiptasjúkdóma
DK1117676T3 (da) Propanolaminderivater bundet til galdesyrer til behandling af forstyrrelser i lipidstofskiftet
IS5218A (is) Staðgengar bensópýranafleiður til meðferðar á bólgu
DK0967214T3 (da) Intranasale formuleringer til behandling af seksuelle forstyrrelser
EP1254899A3 (en) Piperazine derivatives and their use as anti-inflammatory agents
DK0897970T3 (da) Fremgangsmåde til fremstilling af stanolestere
EP0837688A4 (en) HERBAL COMPOSITIONS AGAINST HEPATIC DISORDERS
AU9287401A (en) Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
DK1223925T3 (da) Fedtsyrederivat til behandling af eksterne sekretionslidelser
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
NO994014D0 (no) Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer
AU2003265010A1 (en) Method of treating or preventing obeisity and lipid metabolism disorders and compositions for use therein
IS5333A (is) Prostaglandínafleiður án hliðarverkana til að meðhöndla gláku
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
EE200200429A (et) Kolesteroolestri ja vahaestri sünteesi duaalsed inhibiitorid rasunäärme häirete jaoks
ITMI991856A0 (it) Processo per la preparazione di derivati degli acidi biliari
ID22832A (id) Metode pembuatan asam formilfosfonat
PT1023279E (pt) Compostos e metodo de preparacao de acidos 4-fenil-4-cianociclohexanoicos substituidos
NO20012266L (no) Fremgangsmåte for fremstilling av L-DOPA-etylester
DK0971919T3 (da) Fremgangsmåde til fremstilling af 4H-4-oxo-quinolizin-3-carboxylsyrederivater
DK0998276T3 (da) Anvendelse af alkanoylcarnitinderivater til behandling af attention deficit/hyperactive disorders
NO20015572L (no) Fremgangsmåte til å identifisere terapeutiske forbindelser for behandling av leverlidelser